Showing results 1 to 4 of 4
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Preliminary results from a phase 2 study evaluating VIR-2218 alone and in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection Proceeding/Conference:APASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International | 2022 | |||
Preliminary results from a phase 2 study evaluating vir-2218 alone and in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection Proceeding/Conference:Oral Presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology | 2021 | |||
Rapid HBsAg reduction in chronic hepatitis B virus infection: preliminary results from a phase 1 study evaluating a single dose of VIR-3434, a novel neutralizing, vaccinal monoclonal antibody Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology | 2021 | |||
2016 |